Eiken Licenses LAMP to OptiGene, UK's Veterinary Laboratories Agency | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – OptiGene today announced an agreement to license Eiken Chemical's LAMP gene amplification technology.

Separately, Eiken this week said that it also is licensing the technology to the UK Veterinary Laboratories Agency.

As part of its agreement, OptiGene will develop, manufacture, and sell nucleic acid amplification reagents for research use.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.